Zhejiang Int'l Group Co.,Ltd.

000411

CNE0000008D9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
10.71 ^CNY	+0.09%		+4.39%	-4.46%

Apr. 26	Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Zhejiang Int'l Group Co.,Ltd. Announces Profit Distribution Proposal for 2022

May 04, 2023 at 03:51 pm EDT

Zhejiang Int'l Group Co.,Ltd. announced on 04 May 2023 the profit distribution proposal for 2022 as follows: 1. Cash dividend/10 shares (tax included): CNY 1.26000000.

Latest news about Zhejiang Int'l Group Co.,Ltd.

Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-15	CI
Zhejiang Int'l Group Co.,Ltd. Announces Final Cash Dividend on A Shares for 2022, Payable on 08 June 2023	23-06-01	CI
Zhejiang Int'l Group Co.,Ltd. Approves Cash Dividend for 2022	23-05-22	CI
Zhejiang Int'l Group Co.,Ltd. Announces Profit Distribution Proposal for 2022	23-05-04	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Zhejiang Int'l Group Co.,Ltd. agreed to acquire 51% stake in Hangzhou Baishan Medical Equipment Co., Ltd. from Shanghai Youjiang Enterprise Development Center (Limited Partnership), Shanghai Tuyu Enterprise Development Center (Limited Partnership), Yun Naiyi and Huang Haihua for CNY 100 million.	23-04-11	CI
Zhejiang International to Buy Out Local Pharma Firm in 1.2 Billion Yuan Share Transfer Deal	23-04-11	MT
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-10	CI
Zhejiang Int'l Group Co.,Ltd. announced that it has received CNY 399.999996 million in funding from Zhejiang CONBA Pharmaceutical Co.,Ltd.	23-03-15	CI
Zhejiang International Secures Nod to Sell 400 Million Yuan of Shares	23-03-02	MT
Zhejiang Int'l Group Co.,Ltd. completed the acquisition of remaining 50% stake in Zhejiang Int'l Medicine Co., Ltd. from Zhejiang Huachen Investment Development Co. Ltd. and Zhejiang International Business Group Co.,Ltd.	23-02-27	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Zhejiang Int'l Group Co.,Ltd. announces decision of Shareholder/Board on the transaction	22-10-24	CI
Zhejiang Int'l Group Co.,Ltd. announced that it expects to receive CNY 400 million in funding	22-10-24	CI
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Zhejiang Int'l Group Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 17 June 2022	22-06-13	CI
Zhejiang Int'l Group Co.,Ltd. agreed to acquire remaining 50% stake in Zhejiang Int'l Medicine Co., Ltd. from Zhejiang Huachen Investment Development Co. Ltd. and Zhejiang International Business Group Co.,Ltd for CNY 2.3 billion.	22-05-25	CI
Zhejiang Int'l Group Co.,Ltd. announced that it expects to receive CNY 449.99955 million in funding from Zhejiang CONBA Pharmaceutical Co.,Ltd.	22-05-24	CI
Zhejiang Int'l Group Co.,Ltd. Approves Cash Dividend for the Year 2021	22-05-13	CI
Zhejiang International Halts Trading on M&A Plan	22-05-12	MT
Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
INT'LÂ Group Announces Final Profit Distribution Proposal for 2021	22-04-20	CI

Chart Zhejiang Int'l Group Co.,Ltd.

Duration

Period

More charts

ZHEJIANG INT'L GROUP CO., LTD. is a China-based company principally engaged in the wholesale and retail of pharmaceuticals and medical equipment. The Company purchases products from pharmaceutical manufacturers or suppliers, then wholesales them to distributors, medical institutions and pharmacies, or sells them directly to consumers through retail terminals. The Company conducts its businesses in Mainland China.

Sector

Pharmaceuticals

Calendar

2024-04-26 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
ZHEJIANG INT'L GROUP CO.,LTD.	-4.46%	772M
MCKESSON CORPORATION	+17.35%	71.39B
CARDINAL HEALTH, INC.	+2.39%	25.1B
SINOPHARM GROUP CO. LTD.	+5.38%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.69%	8.19B
HUADONG MEDICINE CO., LTD	-20.96%	7.91B
H. LUNDBECK A/S	+0.49%	4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.31B
EBOS GROUP LIMITED	-3.38%	3.93B
GALENICA AG	-2.61%	3.86B